Cymbalta Maker Opposes Allowing Victims to Combine Forces in Lawsuit

Tuesday, September 16, 2014

Last week, DrugNews reported that lawyers have filed lawsuits in 15 different states for victims of severe Cymbalta withdrawal side effects, and see the number of cases growing quickly.

In an attempt to streamline the growing litigation against Eli Lilly for the defective drug, and give thousands of patients a more efficient means of legal recourse, lawyers last month asked that cases be combined under one judge in a special federal court, instead of being spread around the country.

Lawyers representing Cymbalta patients overwhelmingly support the move, as it will create a Cymbalta MDL just for these cases and allow a quick determination of whether Eli Lilly covered up side effect occurrence rates and severity.

However, sources reported this week that the pharmaceutical giant opposes the creating of a special Cymbalta lawsuit court, arguing that cases are vastly different and that the publicity will lead to additional litigation.

Until recently, Cymbalta was Lilly’s top-selling med, earning billions of dollars each year. On the market since 2004, it is now prescribed for a variety of conditions, including depression, anxiety, fibromyalgia and pain.

Initially, maker Eli Lilly told patients that around 1% of users may experience side effects while trying to stop taking the medicine. However, reports now show the company hid data showing the occurrence rate of severe withdrawals could be over 50%.

Also, Lilly didn’t give patients a viable means of tapering off Cymbalta. Thousands so far have complained of symptoms ranging from headaches and irritability to strong electrical-like shocks to the brain.

Regardless of Eli Lilly’s resistance to litigation, lawyers expect the company will be liable for damages to its patients. They are currently helping anyone affected file lawsuits.


Other drugs and devices in the news:

Friday, August 9, 2019
Surgical Stapler
Did Surgical Staple Companies Hide Thousands of Injuries?

This past spring, the FDA issued a warning affecting the millions of patients each year that undergo routine gastrointestinal, gynecologic...

Friday, August 2, 2019
Invokana Gangrene Amputation
Federal Panel Adds Fournier's Gangrene to Crowded Invokana MDL Court

In the latest Invokana lawsuit update, DrugNews has learned that a federal judicial panel has transferred new cases alleging...

Get in touch with us.

Call, email or live chat with us today to see how we can help.

Need a quick answer? Call us!
Reach out to us by email.
live chat with DrugNews
We are here to help now